✦ LIBER ✦

Phase I and pharmacologic study of 7- and 21-day continuous etoposide infusion in patients with advanced cancer

✍ Scribed by F. Robert; Shande Chen; Antonius A. Miller; Beverly C. Lee; David C. Molthrop; Richard H. Wheeler

Publisher: Springer
Year: 1996
Tongue: English
Weight: 156 KB
Volume: 38
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800050511

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase-I dose escalation and sequencing s

Phase-I dose escalation and sequencing study of docetaxel and continuous infusion topotecan in patients with advanced malignancies

✍ James A. Posey; Hui Wang; JoElle Hamilton; Alma Delgrosso; Ruiwen Zhang; Timothy 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 251 KB

Phase II study of oral etoposide for pat

Phase II study of oral etoposide for patients with advanced breast cancer

✍ Daniel M. Atienza; Charles L. Vogel; Bruce Trock; Sandra M. Swain 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 562 KB

Phase I study of etoposide, cisplatin an

Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer

✍ E. Briasoulis; E. Samantas; H. Kalofonos; D. Skarlos; T. Makatsoris; C. Christod 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 376 KB

Phase I and pharmacologic evaluation of

Phase I and pharmacologic evaluation of nafazatrom in patients with cancer

✍ Charles D. Haas; Laurence H. Baker; Llewelyn J. Evans 📂 Article 📅 1984 🏛 Springer US 🌐 English ⚖ 306 KB

Nafazatrom was evaluated in escalating daily oral doses ranging from 0.25 to 8.0 g/m 2 without producing significant toxicities. Malabsorption proved dose limiting at 8.0 g/m 2 as a single daily dose, but splitting the same total dose into two or four doses circumvented this problem. Doses of 2.0 g/

Continuous infusion 5-fluorouracil with

Continuous infusion 5-fluorouracil with escalating doses of intermittent cisplatin and etoposide. A phase I study

✍ Thomas Saphner; Douglass C. Tormey; Mark Albertini 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 401 KB 👁 2 views

Phase I study of high-dose cytosine arab

Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies

✍ Bayard L. Powell; Hyman B. Muss; Robert L. Capizzi; Mary E. Caponera; Douglas R. 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 273 KB